CD4+ and CD8+ T Cells Exert Regulatory Properties during Experimental Acute Aristolochic Acid Nephropathy

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Baudoux, Thomas ^a,b   Husson, Cécile ^a   De Prez, Eric ^a   Jadot, Inès ^c   Antoine, Marie Hélène ^a   Nortier, Joëlle L ^a,b   Hougardy, Jean Michel ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c University of Namur   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; KIDNEY; LYMPHOCYTE DEPLETION; MALE; METABOLISM; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SPLEEN;

ACUTE KIDNEY INJURY; ANIMALS; ARISTOLOCHIC ACIDS; BIOMARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPHENOTYPING; KIDNEY; LYMPHOCYTE DEPLETION; MALE; MICE; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 85044511320     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-23565-2     Document Type: Article

References (43)

1. Vanherweghem, J. L. et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341, 387-391 (1993).
2. Vanhaelen, M., Vanhaelen-Fastre, R., But, P. &Vanherweghem, J. L. Identification of aristolochic acid in Chinese herbs. Lancet 343, 174 (1994).
3. Debelle, F. D., Vanherweghem, J. L. &Nortier, J. L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74, 158-169 (2008).
4. Depierreux, M., Van Damme, B., Vanden Houte, K. &Vanherweghem, J. L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24, 172-180 (1994).
5. Cosyns, J. P. et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int. 45, 1680-1688 (1994).
6. Cosyns, J. P. et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int. 59, 2164-2173 (2001).
7. Debelle, F. D. et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 13, 431-436 (2002).
8. Sato, N. et al. Acute nephrotoxicity of aristolochic acids in mice. J. Pharm. Pharmacol. 56, 221-229 (2004).
9. Shibutani, S. et al. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 35, 1217-1222 (2007).
10. Pozdzik, A. A. et al. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol. Dial. Transplant. 23, 2480-2491 (2008).
11. Pozdzik, A. A. et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73, 595-607 (2008).
12. Meng, X. M., Nikolic-Paterson, D. J. &Lan, H. Y. Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10, 493-503 (2014).
13. Baudoux, T. E. et al. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy. Kidney Int. 82, 1105-1113 (2012).
14. Gandolfo, M. T. et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 76, 717-729 (2009).
15. Kinsey, G. R. et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J. Am. Soc. Nephrol. 20, 1744-1753 (2009).
16. Mahajan, D. et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J. Am. Soc. Nephrol. 17, 2731-2741 (2006).
17. Wang, Y. M. et al. Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J. Am. Soc. Nephrol. 17, 697-706 (2006).
18. Lee, H. et al. CD4(+)CD25(+) regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. (2010).
19. Jang, H. R. &Rabb, H. Immune cells in experimental acute kidney injury. Nat Rev Nephrol 11, 88-101 (2015).
20. Baudoux, T. &Nortier, J. L. Nephrotoxicity of Herbal Products. in Toxicology of Herbal Products (eds Pelkonen, O., Duez, P., Vuorela, P. M. &Vuorela, H.) 307-344 (Springer International Publishing, Cham 2017).
21. Pozdzik, A. A. et al. Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology 56, 449-463 (2010).
22. Vanherweghem, J. L., Abramowicz, D., Tielemans, C. &Depierreux, M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am. J. Kidney Dis. 27, 209-215 (1996).
23. Liu, M. et al. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J. Am. Soc. Nephrol. 17, 765-774 (2006).
24. Burne, M. J. et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108, 1283-1290 (2001).
25. Hochegger, K. et al. Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 293, F741-747 (2007).
26. Tapmeier, T. T. et al. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int. 78, 351-362 (2010).
27. Monteiro, R. M. et al. A role for regulatory T cells in renal acute kidney injury. Transpl. Immunol. 21, 50-55 (2009).
28. Kinsey, G. R., Huang, L., Vergis, A. L., Li, L. &Okusa, M. D. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int. 77, 771-780 (2010).
29. Wang, Y. et al. Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Kidney Int. 59, 975-984 (2001).
30. Chaves, L. D. et al. Contrasting effects of systemic monocyte/macrophage and CD4+ T cell depletion in a reversible ureteral obstruction mouse model of chronic kidney disease. Clinical &developmental immunology 2013, 836989 (2013).
31. Ascon, D. B. et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J. Immunol. 177, 3380-3387 (2006).
32. Ascon, D. B. et al. Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J. Leukoc. Biol. 84, 1400-1409 (2008).
33. Fujiu, K., Manabe, I. &Nagai, R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121, 3425-3441 (2011).
34. Kawakami, T. et al. Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions. J. Immunol. 191, 3358-3372 (2013).
35. Belliere, J. et al. Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury. J. Am. Soc. Nephrol. 26, 1363-1377 (2015).
36. Cao, Q., Harris, D. C. &Wang, Y. Macrophages in kidney injury, inflammation, and fibrosis. Physiology (Bethesda, Md.) 30, 183-194 (2015).
37. Lee, S. et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22, 317-326 (2011).
38. Wang, Y. et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 72, 290-299 (2007).
39. Cao, Q. et al. IL-10/TGF-{beta}-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis. J. Am. Soc. Nephrol. (2010).
40. Chan, T., Pek, E. A., Huth, K. &Ashkar, A. A. CD4(+) T-cells are important in regulating macrophage polarization in C57BL/6 wild-type mice. Cell. Immunol. 266, 180-186 (2011).
41. Tadagavadi, R. K. &Reeves, W. B. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J. Am. Soc. Nephrol. 21, 53-63 (2010).
42. Kim, K. D. et al. Adaptive immune cells temper initial innate responses. Nat. Med. 13, 1248-1252 (2007).
43. Inoue, M. et al. T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc. Natl. Acad. Sci. USA 111, 5295-5300 (2014).